CBOE vs ORMP
Cboe Global Markets Inc (CBOE) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
CBOE does not have a complete income-statement cache yet.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the CBOE and ORMP stock pages for the full models.
Not investment advice.